ArticleCancer cell2021

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma.

Oliver Van Oekelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.